Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: ASAIO J. 2022 Feb 27;68(12):1450–1458. doi: 10.1097/MAT.0000000000001690

Table 4.

Driveline Infection: Incidence and Management Strategies by Era (N = 87)

Entire cohort Era 1 Era 2 Era 3 Era 4 P value

Number of patients 87 21 42 12 12
Time to DLI development, days* 403 [530] 442 [618] 397.5 [463.2] 404.5 [464.2] 378 [303.7] 0.8557
Time to initiation of antibiotics, days* 0 [3] 0 [7] 0 [3.25] 0 [1] 0 [0.5] 0.2617
Initial antibiotic strategy 0.0647
Oral, n (%) 54 (62.07) 18 (85.71) 23 (54.76) 7 (58.33) 6 (50.00)
IV, n (%) 33 (37.93) 3 (14.29) 19 (45.24) 5 (41.67) 6 (50.00)
CAS, n (%) 57 (65.52) 11 (52.38) 27 (64.29) 9 (75.00) 10 (83.33) 0.5076
Abdominal CT scan within 30 days of DLI diagnosis, n (%) 33 (37.93) 4 (19.05) 19 (45.24) 5 (41.67) 5 (41.67) 0.7454
Incision and drainage ≤30 days from DLI diagnosis, n (%) 13 (14.94) 1 (4.76) 6 (14.29) 3 (25.00) 3 (25.00) 0.4496
Wound VAC, ≤30 days from DLI diagnosis, n (%) 12 (13.79) 1 (4.76) 6 (14.28) 2 (16.67) 3 (25.00) 0.5385
Incision and drainage >30 days after DLI diagnosis, n (%) 25 (28.74) 6 (28.57) 7 (16.67) 6 (50.00) 6 (50.00) 0.3926
Wound VAC >30 days from DLI diagnosis, n (%) 23 (26.44) 4 (19.05) 7 (16.67) 6 (50.00) 6 (50.00) 0.1500
Driveline re-routing, n (%) 2 (2.30) 2 (9.52) 0 (0.00) 0 (0.00) 0 (0.00) 0.0690
Device exchange due to DLI, n (%) 5 (5.75) 1 (4.76) 4 (9.52) 0 (0.00) 0 (0.00) 0.3007
*

Data presented as median (interquartile range).

CAS, chronic antibiotic suppression; CT, computed tomography; DLI, driveline infection; LVAD, left ventricular assist device; VAC, vacuum-assisted closure.